Runben Biotechnology's major shareholder JNRY VIII has completed a 3% share reduction
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Runben Biotechnology announced that its shareholder JNRY VIII HK Holdings Limited (referred to as "JNRY VIII"), which holds more than 5% of the shares, has cumulatively reduced its holdings by 12.1378 million shares, accounting for 3.00% of the total share capital. This reduction plan has been completed
According to the Zhitong Finance APP, Runben Biotechnology (603193.SH) announced that its shareholder holding more than 5%, JNRY VIII HK Holdings Limited (referred to as "JNRY VIII"), has cumulatively reduced its holdings by 12.1378 million shares, accounting for 3.00% of the total share capital. This reduction plan has been completed